PHR:NYE-Phreesia Inc (USD)

COMMON STOCK | Health Information Services |

Last Closing

USD 24.49

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.67M

Analyst Target

USD 30.11
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-31 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
DOCS Doximity Inc

+2.01 (+3.90%)

USD 11.11B
WEAV Weave Communications Inc

+0.23 (+2.45%)

USD 0.72B
AMWL American Well Corp

+0.33 (+5.02%)

USD 0.11B
CTEV Claritev Corporation

-0.66 (-1.73%)

N/A
HNGE Hinge Health, Inc.

-0.11 (-0.27%)

N/A
EVH Evolent Health Inc

+0.98 (+12.95%)

N/A
TDOC Teladoc Inc

+0.19 (+2.77%)

N/A
VEEV Veeva Systems Inc Class A

+6.12 (+2.20%)

N/A
FOXO FOXO Technologies Inc.

N/A

N/A

ETFs Containing PHR

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -2.66% 63% D 40% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -2.66% 63% D 37% F
Trailing 12 Months  
Capital Gain 29.44% 75% C 90% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 29.44% 75% C 90% A-
Trailing 5 Years  
Capital Gain -18.58% 50% F 21% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -18.58% 50% F 13% F
Average Annual (5 Year Horizon)  
Capital Gain -0.63% 60% D- 33% F
Dividend Return -0.63% 60% D- 21% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 53.05% 70% C- 14% F
Risk Adjusted Return -1.19% 60% D- 24% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector